AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
NCT ID: NCT01976299
Last Updated: 2017-02-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
578 participants
INTERVENTIONAL
2013-12-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
NCT00235287
Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV)
NCT01168024
Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention
NCT01399203
Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury
NCT01209169
Carotid Doppler and IVC Measurements for Volume Guided Management in Acute Kidney Injury Patients
NCT05938049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Treatment
Standard of Care with the AVERT system
AVERT
Standard of Care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AVERT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject has documented chronic kidney disease (CKD)
Exclusion Criteria
* Assessment of ventricular function that cannot be accomplished without the use of the CM.
* Subject has acute STEMI within 72 hours prior to planned PCI procedure, or is currently having an acute STEMI.
* Subject is unable to undergo peri-procedural hydration.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Osprey Medical, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roxana Mehran, MD, FACC
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSD Medical Center
La Jolla, California, United States
Long Beach CA VA Hospital
Long Beach, California, United States
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
Stanford Hospital and Clinics
Stanford, California, United States
Harbor UCLA Medical Center
Torrance, California, United States
The Heart & Vascular Institute of Florida
Clearwater, Florida, United States
University of FL College of Medicine - Jacksonville
Jacksonville, Florida, United States
St. Vincent's Ambulatory Care (dba St. Vincent's Cardiology)
Jacksonville, Florida, United States
Tallahassee Research Institute, Inc.
Tallahassee, Florida, United States
Emory University Hospital Midtown
Atlanta, Georgia, United States
St. Joseph's Hospital (Emory)
Atlanta, Georgia, United States
Coliseum Medical Center
Macon, Georgia, United States
University of Illinois at Chicago
Chicago, Illinois, United States
University of Chicago Medical Center
Chicago, Illinois, United States
Jewish Hospital
Louisville, Kentucky, United States
Norton Cardiovascular Associates
Louisville, Kentucky, United States
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Minneapolis Heart Institute Foundation / Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
Mayo Clinic Hospital, St. Mary's Campus
Rochester, Minnesota, United States
North Mississippi Medical Center
Tupelo, Mississippi, United States
Saint Luke's Hospital
Kansas City, Missouri, United States
Gateway Cardiovascular Research Center, Inc.
St Louis, Missouri, United States
Mount Sinai Hospital
New York, New York, United States
LeBauer Cardiovascular Research Foundation
Greensboro, North Carolina, United States
NC Heart and Vascular Research
Raleigh, North Carolina, United States
Oklahoma Heart
Oklahoma City, Oklahoma, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
York Hospital
York, Pennsylvania, United States
Providence Cardiology LLC
Columbia, South Carolina, United States
Baptist Memorial Hospital
Memphis, Tennessee, United States
VA North Texas Health Care System
Dallas, Texas, United States
CHI St. Luke's Health / Baylor St. Luke's Medical Center
Houston, Texas, United States
Houston Methodist Hospital
Houston, Texas, United States
The Heart Hospital Baylor Plano
Plano, Texas, United States
U of TX Health Science Center San Antonio (UTHSCSA)
San Antonio, Texas, United States
Trinity Mother Frances/Cardiovascular Associates of East Texas PA
Tyler, Texas, United States
Sentara Cardiovascular Research Institute / Norfolk General
Norfolk, Virginia, United States
Heart Center Alfred Hospital
Melbourne, Victoria, Australia
Auckland City Hospital
Auckland, , New Zealand
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mehran R, Faggioni M, Chandrasekhar J, Angiolillo DJ, Bertolet B, Jobe RL, Al-Joundi B, Brar S, Dangas G, Batchelor W, Prasad A, Gurm HS, Tumlin J, Stone GW. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography. JACC Cardiovasc Interv. 2018 Aug 27;11(16):1601-1610. doi: 10.1016/j.jcin.2018.04.007.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TP-6364
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.